These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20216929)

  • 1. The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart.
    La Bonte LR; Dokken B; Davis-Gorman G; Stahl GL; McDonagh PF
    Diab Vasc Dis Res; 2009 Jul; 6(3):172-80. PubMed ID: 20216929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion.
    La Bonte LR; Davis-Gorman G; Stahl GL; McDonagh PF
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1282-90. PubMed ID: 18178726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.
    Povlsen JA; Løfgren B; Rasmussen LE; Nielsen JM; Nørregaard R; Kristiansen SB; Bøtker HE; Nielsen TT
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):892-8. PubMed ID: 19298538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury.
    Jordan JE; Montalto MC; Stahl GL
    Circulation; 2001 Sep; 104(12):1413-8. PubMed ID: 11560858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin.
    Busche MN; Pavlov V; Takahashi K; Stahl GL
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1853-9. PubMed ID: 19749170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.
    Yue TL; Bao W; Gu JL; Cui J; Tao L; Ma XL; Ohlstein EH; Jucker BM
    Diabetes; 2005 Feb; 54(2):554-62. PubMed ID: 15677515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.
    Lu F; Fernandes SM; Davis AE
    Cardiovasc Pathol; 2013; 22(1):75-80. PubMed ID: 22705194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury.
    Walsh MC; Bourcier T; Takahashi K; Shi L; Busche MN; Rother RP; Solomon SD; Ezekowitz RA; Stahl GL
    J Immunol; 2005 Jul; 175(1):541-6. PubMed ID: 15972690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against intercellular adhesion molecule 1 protect against myocardial ischaemia-reperfusion injury in rat.
    Ioculano M; Squadrito F; Altavilla D; Canale P; Squadrito G; Campo GM; Saitta A; Caputi AP
    Eur J Pharmacol; 1994 Oct; 264(2):143-9. PubMed ID: 7851476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction.
    Haas MS; Alicot EM; Schuerpf F; Chiu I; Li J; Moore FD; Carroll MC
    Cardiovasc Res; 2010 Sep; 87(4):618-27. PubMed ID: 20462867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.
    Povlsen JA; Løfgren B; Dalgas C; Birkler RI; Johannsen M; Støttrup NB; Bøtker HE
    PLoS One; 2013; 8(5):e64093. PubMed ID: 23704975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nothing but natural: targeting natural IgM in ischaemia/reperfusion injury.
    Hofmann U; Bauersachs J; Frantz S
    Cardiovasc Res; 2010 Sep; 87(4):589-90. PubMed ID: 20573731
    [No Abstract]   [Full Text] [Related]  

  • 16. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury.
    de Vries B; Walter SJ; Peutz-Kootstra CJ; Wolfs TG; van Heurn LW; Buurman WA
    Am J Pathol; 2004 Nov; 165(5):1677-88. PubMed ID: 15509537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.
    Kristiansen SB; Løfgren B; Støttrup NB; Khatir D; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Flyvbjerg A
    Diabetologia; 2004 Oct; 47(10):1716-21. PubMed ID: 15480537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of regulatory T cells attenuates the protective effects of myocardial ischemic preconditioning in rats.
    Ke D; Fang J; Fan L; Chen L
    Scand Cardiovasc J; 2015 Feb; 49(1):64-71. PubMed ID: 25580940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.